135 related articles for article (PubMed ID: 29231748)
1. Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis.
Yan S; DerSarkissian M; Bhak RH; Lefebvre P; Duh MS; Krishnarajah G
Curr Med Res Opin; 2018 Jul; 34(7):1261-1269. PubMed ID: 29231748
[TBL] [Abstract][Full Text] [Related]
2. Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization.
Hechter RC; Qian L; Yan S; Luo Y; Krishnarajah G; Tseng HF
BMC Health Serv Res; 2017 Jul; 17(1):503. PubMed ID: 28732518
[TBL] [Abstract][Full Text] [Related]
3. Is patient insurance type related to physician recommendation, administration and referral for adult vaccination? A survey of US physicians.
McNamara M; Buck PO; Yan S; Friedland LR; Lerch K; Murphy A; Hogea C
Hum Vaccin Immunother; 2019; 15(9):2217-2226. PubMed ID: 30785363
[TBL] [Abstract][Full Text] [Related]
4. Insurance Reimbursements for Routinely Recommended Adult Vaccines in the Private Sector.
Tsai Y; Zhou F; Lindley MC
Am J Prev Med; 2019 Aug; 57(2):180-190. PubMed ID: 31248743
[TBL] [Abstract][Full Text] [Related]
5. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability.
La EM; Trantham L; Kurosky SK; Odom D; Aris E; Hogea C
Hum Vaccin Immunother; 2018 Feb; 14(2):430-441. PubMed ID: 29194019
[TBL] [Abstract][Full Text] [Related]
6. Noninfluenza vaccination coverage among adults - United States, 2012.
Williams WW; Lu PJ; O'Halloran A; Bridges CB; Pilishvili T; Hales CM; Markowitz LE;
MMWR Morb Mortal Wkly Rep; 2014 Feb; 63(5):95-102. PubMed ID: 24500288
[TBL] [Abstract][Full Text] [Related]
7. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
8. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
Thierry-Carstensen B; Jordan K; Uhlving HH; Dalby T; Sørensen C; Jensen AM; Heilmann C
Vaccine; 2012 Aug; 30(37):5464-71. PubMed ID: 22776216
[TBL] [Abstract][Full Text] [Related]
9. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA.
Pool V; Tomovici A; Johnson DR; Greenberg DP; Decker MD
Vaccine; 2018 Apr; 36(17):2282-2287. PubMed ID: 29573876
[TBL] [Abstract][Full Text] [Related]
10. Predictors of tetanus-diphtheria- acellular pertussis vaccination among adults receiving tetanus vaccine in the United States: data from the 2008 national health interview survey.
Johns TL; Roetzheim R; Chen R
J Prim Care Community Health; 2013 Apr; 4(2):95-100. PubMed ID: 23799715
[TBL] [Abstract][Full Text] [Related]
11. Vaccination coverage among adults, excluding influenza vaccination - United States, 2013.
Williams WW; Lu PJ; O'Halloran A; Bridges CB; Kim DK; Pilishvili T; Hales CM; Markowitz LE;
MMWR Morb Mortal Wkly Rep; 2015 Feb; 64(4):95-102. PubMed ID: 25654611
[TBL] [Abstract][Full Text] [Related]
12. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
Kretsinger K; Broder KR; Cortese MM; Joyce MP; Ortega-Sanchez I; Lee GM; Tiwari T; Cohn AC; Slade BA; Iskander JK; Mijalski CM; Brown KH; Murphy TV; ; ;
MMWR Recomm Rep; 2006 Dec; 55(RR-17):1-37. PubMed ID: 17167397
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
[TBL] [Abstract][Full Text] [Related]
14. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.
Kovac M; Kostanyan L; Mesaros N; Kuriyakose S; Varman M
Hum Vaccin Immunother; 2018; 14(8):1977-1986. PubMed ID: 29630439
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.
Sirivichayakul C; Chanthavanich P; Limkittikul K; Siegrist CA; Wijagkanalan W; Chinwangso P; Petre J; Hong Thai P; Chauhan M; Viviani S
Hum Vaccin Immunother; 2017 Jan; 13(1):136-143. PubMed ID: 27686283
[TBL] [Abstract][Full Text] [Related]
17. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
Sricharoenchai S; Sirivichayakul C; Chokephaibulkit K; Pitisuttithum P; Dhitavat J; Pitisuthitham A; Phongsamart W; Boonnak K; Lapphra K; Sabmee Y; Wittawatmongkol O; Chinwangso P; Poredi IK; Petre J; Thai PH; Viviani S
Lancet Infect Dis; 2018 Jan; 18(1):58-67. PubMed ID: 29066131
[TBL] [Abstract][Full Text] [Related]
18. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
19. Physician Attitudes Toward Adult Vaccines and Other Preventive Practices, United States, 2012.
Hurley LP; Bridges CB; Harpaz R; Allison MA; O' Leary ST; Crane LA; Brtnikova M; Stokley S; Beaty BL; Jimenez-Zambrano A; Kempe A
Public Health Rep; 2016; 131(2):320-30. PubMed ID: 26957667
[TBL] [Abstract][Full Text] [Related]
20. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
